We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Deutsche Bank starts TP ICAP with 'buy' - price target 264 pence
Anyone know the potential timeframe for minority stake sale of Parameta?
Thanks
JPMorgan raises TP ICAP price target to 274 (259) pence - 'overweight'
But looking like the share buy backs will keep the sp where it is. Gap close looking unlikely until at least share buy back complete
Indeed I thought impossible. But in fact it may drop to touch 200p to close the gap!
It doesn't really need to dip lower as the gap fill is around 200-201p. But as per normal - it may dip below intraday.
That would be a huge last chance to buy under £2. However - will this happen or not remains to be seen. Best of luck to all!
Think we will retest sub £2 as we await new. A buy the dips for sure.
Highest high since May 2021, means virtually no overhead resistance , from previous trading. Also volatility based bollinger bands, separating confirms high current volatility. Large upper wick, means rejection of even higher sp, on the day. The sp, may require to settle down, especially after the large gap up, before resuming uptrend. The uptrend, is not in doubt, because it is confirmed by the relative strength index, being above 50.
I would prefer to hold on to parameta.
Everyone wants it.
Let them bid themselves whoever they are, if they want it
N Breteau has been an excellent CEO since he took over and has guided the company towards electonification, cost controls and diversification. Spot on.
Https://open.substack.com/pub/theoakbloke/p/tcap-problem-we-have-a-houston
https://theoakbloke.substack.com/p/introducing-tp-icap
X-divi date is still a month away. Plus broker upgrades and share buy backs mean this should push higher to 240-260p in a month.
Up 12% today on open to 226p
The slice I took on 10/8/22 for 150p after similar day rise made to soon with hindsight , but only sold the cheaper buy six months before for 126p . Topped out at 198p 3/10/22 but then fell back again to 143p by 11/7/23.
This clip from December 2023. when it was around 200p ( They buy before tipping ? ) came back to 179p last month.
Christopher Mills from Harwood Capital talks about TCAP at 54:20
https://www.youtube.com/watch?v=M_iIre1pAW4&t=3260s
Happy days
And patients paid off ,excellent
Has anyone found how to access this. The results say it's available but links to a download of the slides not the actual webcast.
Investor Relations pages no help either.
Come on get the basics sorted
Wow
We have met, or exceeded, the majority of our revised 2023 targets. Since our Capital Markets Day in 2020, the Group is growing the top line, is more diversified, more profitable, and more cash generative. We are committed to creating sustainable shareholder value by investing for growth in our market-leading businesses, maximising the value of our strategic assets, and delivering strong cash generation and dynamic capital management."
Way to go to double SP 👏 👍 🙌 💪
Way to go to double SP 👏 👍 🙌 💪
Parameta Solutions, our highly valuable data business, continues to grow and develop - winning new clients, and broadening its distribution and product suite. The Board believes that Parameta's significant growth prospects, and the intrinsic value of the business, are not appropriately reflected in our share price. We are therefore exploring options for unlocking value for shareholders, whilst retaining ownership of the asset, which include a potential IPO of a minority stake in the business.
Very acceptable results ... Divi paument very welcome, as is share buyback, plus part IPO Para'.
It is looking good especially with the reference to the Parameta listing.
Our focus on productivity, contribution and cost management generated an 8% uplift in Group adjusted EBIT to £300m, the highest level of profit ever achieved by the Group.
Https://www.londonstockexchange.com/news-article/TCAP/final-results/16372237
The Second Buyback highlights the Board's confidence in the future prospects of TP ICAP, reflects its strong financial position, and is consistent with its dynamic capital management strategy, which is a key priority. This means reducing our debt, and returning surplus capital to shareholders, subject to our ongoing investment needs and balance sheet requirements.
With this one any plunges I buy especially now. The FT do not post stories lightly.
https://archive.ph/tgLmp
It does seem odd. Even if the liquidnet value is written down to zero which i understand is not the case as they are gaining traction, albeit not necessarily in the imagined direction, the core broking business should be printing money with the past years vola in rates (unless the brokers are overpaid) . Clearly we are missing something here, hopefully all comes a bit clearer tomorrow.
Gamechanger
Seems a strange one - still readded as I was underinvested here.
LT a winner, dislike chasing but the Parmeta listing makes this a £3/£4 share when confirmed.